Today, on International Nurses Day, at a time when clinical trials are being discussed on a daily basis regarding the COVID-19 crisis, Cure Leukaemia highlights how the crisis could impact blood cancer patients
Check out In Vivo’s list of “ones to watch” in Biopharma and Medtech. Optimum clients Derk Arts, Castor CEO, Jason Foster, Ori Biotech CEO and Greg Mullen, Theragnostics CEO recognised for “bringing something new to the game”.
RNA epigenetics is an “untapped druggable space” that could be the next breakthrough/ frontier for innovative treatments for cancer and a broad array of other conditions. What is more, is that it lends itself to small molecule drugs adding to the small molecule armamentarium of targeted drugs for cancer that are giving doctors and their […]
Optimum aims to provide you with the most informative insights on the current COVID-19 pandemic. The below renowned publications are striving to provide the best and most timely research, analysis, and news coverage of COVID-19 and the coronavirus that causes it. All content is currently free to access and is available at the below links. […]
“A viable therapeutic would dramatically change the tone of the COVID-19 pandemic, giving hope and a path to eradicating the virus, saving lives and livelihoods.”
